| Income Statement |
| Total Revenue | 843.00M |
|
| Revenues (USD) | 843.00M |
| Cost of Revenue | 378.00M |
| Gross Profit | 465.00M |
| Operating Expenses | 461.00M |
| Research and Development Expense | 115.00M |
| Selling, General and Administrative Expense | 312.00M |
| Operating Income | 4.00M |
| Income Tax Expense | 4.00M |
| Earning Before Interest & Taxes (EBIT) | 4.00M |
| Earning Before Interest & Taxes (USD) | 4.00M |
| Weighted Average Shares | 281.00M |
| Weighted Average Shares Diluted | 281.00M |
| Balance Sheet |
| Cash and Equivalents | 207.00M |
| Cash and Equivalents (USD) | 207.00M |
| Trade and Non-Trade Receivables | 782.00M |
| Current Assets | 1.42B |
| Property, Plant & Equipment Net | 736.00M |
| Total Assets | 4.72B |
| Current Liabilities | 782.00M |
| Total Liabilities | 1.10B |
| Accumulated Retained Earnings (Deficit) | -116.00M |
| Accumulated Other Comprehensive Income | -14.00M |
| Shareholders Equity | 3.62B |
| Shareholders Equity (USD) | 3.62B |
| Assets Non-Current | 3.30B |
| Goodwill and Intangible Assets | 2.36B |
| Inventory | 356.00M |
| Liabilities Non-Current | 316.00M |
| Trade and Non-Trade Payables | 429.00M |
| Tax Assets | 58.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 41.00M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -91.00M |
| Capital Expenditure | -41.00M |
| Net Cash Flow from Investing | -41.00M |
| Net Cash Flow from Operations | -49.00M |
| Effect of Exchange Rate Changes on Cash | -1000.00K |
| Share Based Compensation | 10.00M |